Essex Small/Micro Cap Growth Fund  (MBRSX)

Fund Overview

Fund Overview

Share Class


Morningstar | Style Box


NAV | as of 09/21/2017

-$0.07 (-0.25%)

Quarterly Performance (%) |
vs. Benchmark as of 06/30/2017

Fund Inception 09/28/2000

MBRSX 12.26 29.44 6.06 14.74 5.72 9.66
Russell 2000® Growth Index 9.97 24.40 7.64 13.98 7.82 5.18

Expense Ratios

  • Gross Expense Ratio: 1.58%
  • Net Expense Ratio: 1.49%
  • Expense Cap Expiration Date: 10/01/2017

Read Important Investment Disclosures


The Fund seeks to achieve long-term capital appreciation by investing primarily in small and micro cap securities.

Why Consider

  • May be suitable for investors seeking exposure to a high conviction portfolio of small to micro cap companies with changing growth prospects reflected by earnings and revenue acceleration
  • The portfolio is constructed with companies transitioning through different phases of growth, exhibiting a diverse range of growth characteristics and industries, across market sectors
  • Allocates to sectors based on fundamental analysis rather than benchmark constraints while relying on fundamental research for security selection

Fund Managers

Nancy Prial, CFA

Co-Chief Executive Officer of Essex & Portfolio Manager

Read Full Bio



Read Important Investment Disclosures

Returns & Distributions

as of 06/30/2017

    • Ex-Date Total Distribution Income Short-term Cap Gains Long-term Cap Gains
      Dec 27, 2016 $0.986500 $0.986500
      Dec 28, 2015 $2.523300 $2.523300
      Dec 26, 2014 $2.333300 $2.333300
      Dec 26, 2013 $3.262400 $0.962700 $2.299700
      Dec 26, 2007 $0.236300 $0.236300
      Dec 26, 2006 $0.094000 $0.094000
      Dec 27, 2005 $0.764000 $0.764000
      Dec 28, 2004 $0.595000 $0.489000 $0.106000
      Dec 26, 2003 $0.160000 $0.100000 $0.060000

Growth of $10,000 (Hypothetical)

Since Inception 09/28/2000 to 08/31/2017 = $47,577.23

  • 3YR
  • 5YR
  • 10YR
  • INCEP.
  • 3YR
  • 5YR
  • 10YR
  • INCEP.

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For performance information through the most recent month end please call 800.835.3879 or visit our website at From time to time, the advisor has waived fees or reimbursed expenses, which may have resulted in higher returns. The listed returns and yields of the Fund are net of expenses, and the returns and yields of the indices exclude expenses. For time periods where the fund inception date preceded the benchmark, the benchmark data will not be shown.

Top Holdings (Equity)

Quarter Ending: 06/30/2017

Cutera Inc 2.14%
Supernus Pharmaceuticals Inc 1.80%
Lantheus Holdings Inc 1.70%
AxoGen Inc 1.65%
Vocera Communications Inc 1.64%
Novanta Inc 1.61%
AXT Inc 1.53%
Intevac Inc 1.45%
Nuvectra Corp 1.42%
Corcept Therapeutics Inc 1.41%
% in Top 10 Holdings 16.35%
View Holding Details Read Important Investment Disclosures

MPT Stats

Month Ending: 08/31/2017

View All Characteristics & Stats

Sector Allocation (Equity)

Quarter Ending: 06/30/2017

Investment Approach

Investment Approach

Essex Small/Micro Cap Growth Fund

Essex believes a company’s price performance is driven by its revenue growth, future profitability and cash flow. The AMG Managers Essex Small/Micro Cap Growth Fund focuses on recognizing an earnings rebound or improvement before the market is able to reflect the improvement in a stock’s price. The Fund focuses on the small cap universe, specifically companies with $50 million to $1.5 billion in market capitalization.

Additional Fund Highlight

Sector weighting is dependent on fundamental analysis rather than benchmark constraints.

Keep Calm and Remain Diversified

A short- and long-term review of the power of diversification.
Read Full Perspective


About Essex Investment Management


Essex manages growth equity portfolios for institutional clients, high net worth clients, mutual funds and private partnerships based on early identification of growth, wherever it exists.

Learn More




Boston, MA



Funds to Consider


DoubleLine Core Plus Bond Fund

The Fund seeks to maximize total return.

Overall Morningstar Rating

Rated against 849 Intermediate-Term Bond funds as of 08/31/2017

Bloomberg Barclays U.S. Aggregate Bond Index

Quarterly performance (%) data as of 06/30/2017

Fund Detail Read Important Investment Disclosures


GW&K Municipal Bond Fund

The Fund seeks to provide current income, exempt from federal income tax, and capital preservation by primarily investing in a portfolio of high-quality municipal bonds.

Overall Morningstar Rating

Rated against 263 Muni National Interm funds as of 08/31/2017

Bloomberg Barclays 10-Year Municipal Bond Index

Quarterly performance (%) data as of 06/30/2017

Fund Detail Read Important Investment Disclosures


Harding Loevner International Equity Portfolio

The Portfolio seeks long-term capital appreciation through investments in equity securities of companies based outside the United States.

Overall Morningstar Rating

Rated against 327 Foreign Large Growth funds as of 08/31/2017


Quarterly performance (%) data as of 06/30/2017

Fund Detail Read Important Investment Disclosures

Discover how AMG Funds brings more than 100 products from over 30 independent boutiques together under one flag.

Learn More About AMG Funds
  Back To Top